Breaking news! Paradigm shift in prostate cancer detection & management led by @Hopkins_Rad @HopkinsNucs clinician scientist @radnucmp. Talk about pushing medicine forward... and now I can say I know someone who the FDA approves of.https://t.co/3FuHZLV5qt #ProstateCancer pic.twitter.com/DqjKeHeCV4
— Pamela Johnson (@PamelaJohnsonMD) May 27, 2021
Game-changer: FDA approved PyL PSMA PET scan which pinpoints location of #prostate cancer that has spread. #PCF’s 25-year #PSMA research investment is saving men’s lives. https://t.co/78JBUgMiQO
— Prostate Cancer Foundation (@PCFnews) May 27, 2021
PCCTC Medical Director @morr316 (@MSKCC_OncoNotes) on the newly FDA approved imaging tool to find advanced prostate cancer via @nbcnews https://t.co/qgjcElDC7D
— The PCCTC (@ThePCCTC) May 27, 2021
Our own @xiaoweimd @DanaFarber_GU quoted on @NBCNews discussing recent @US_FDA PSMA PET approval in prostate cancer; @DanaFarber @DanaFarberNews https://t.co/AyYlkoo87P pic.twitter.com/id0Jrbuyi8
— Toni Choueiri, MD (@DrChoueiri) May 27, 2021
? Breaking News - @US_FDA approves a new imaging tool to find advanced #ProstateCancer. Our Dr. Michael Morris (@morr316) spoke with @DrJohnTorres @NBCNews and @TODAYshow about this game-changing technology. https://t.co/YKgxV0abCS
— Memorial Sloan Kettering Cancer Center (@sloan_kettering) May 27, 2021
"The scan would be most useful for prostate cancer patients who have rising PSA levels after they have undergone treatment, including surgery and radiation, said Dr. Xiao Wei (@xiaoweimd), an oncologist at Dana-Farber Cancer Institute in Boston."https://t.co/SiF1KmKoFG
— Dana-Farber Lank Center for Genitourinary Oncology (@DanaFarber_GU) May 27, 2021